Watchlist Price Alert

Evelo Biosciences Inc. (EVLO)

OTC: EVLO · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 03, 2025, 11:37 AM

Evelo Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-114.53M	-122.18M	-93.67M	-85.47M	-56.95M	-28.05M	-13.33M
Depreciation & Amortization	2.06M	2.22M	2.03M	1.76M	1.94M	834K	495K
Stock-Based Compensation	15.16M	15.85M	8.47M	8.16M	6.06M	1.54M	419K
Other Working Capital	-9.84M	1.91M	6.93M	4.06M	1.39M	1.3M	99K
Other Non-Cash Items	5.74M	2.1M	2.35M	255K	103K	35K	28K
Deferred Income Tax	n/a	3.22M	-6K	-166K	406K	301K	20K
Change in Working Capital	-9.67M	2.07M	7.76M	3.47M	1.16M	2.07M	56K
Operating Cash Flow	-101.23M	-96.72M	-73.06M	-71.98M	-47.28M	-23.27M	-12.31M
Capital Expenditures	-622K	-1.52M	-1.32M	-3.03M	-5.46M	-1.74M	-1.25M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	10.49M
Purchase of Investments	n/a	n/a	n/a	n/a	-136.09M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	55M	81.25M	n/a	n/a
Other Investing Acitivies	n/a	38K	6K	2K	171K	n/a	27K
Investing Cash Flow	-622K	-1.48M	-1.31M	51.97M	-60.13M	-1.74M	9.26M
Debt Repayment	-3.12M	14.78M	10M	4.48M	4.97M	n/a	7M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	234K	1.01M	471K	511K	-128K	64K	1.25M
Financial Cash Flow	81.66M	97.54M	65.47M	4.99M	162.01M	48.97M	15.74M
Net Cash Flow	-20.66M	-666K	-8.91M	-15.02M	54.6M	23.96M	12.69M
Free Cash Flow	-101.86M	-98.24M	-74.38M	-75.01M	-52.74M	-25.01M	-13.56M